Don’t Let Australia’s R&D Tax Incentive Trigger Unintended US International Tax Cost Sharing Issues
4.13.2026Fred Adam
For US technology (including AI), pharma and medical device, biotechnology and life science companies, establishing an Australian subsidiary to access the Australian R&D Tax Incentive (RDTI)—including a refundable tax offset of up to 43.5% of eligible R&D expenditure for eligible entities with aggregated turnover below AUD 20 million—can be an effective way to partially fund clinical trials.
Earlier this year, WilmerHale Partners Dave Gammell, Barry Hurewitz and Jeff Johnson discussed the basics of licensing and legal considerations for university licensing agreements. Here are five things need to know about university licensing.
What’s a tech ’s most valuable asset? It’s not the seed money. It’s not the workspace. And it’s definitely not the espresso machine or Ping Pong table. The priceless heart of a promising is its intellectual property (IP)—the disruptive idea, the brilliant invention, the genius breakthrough.
Tags:
early-stage companies, IP
Terms of use and privacy policies govern the relationship between a company’s website or app and its users, and establish the guidelines for how that company must treat users’ information. Here, our emerging company lawyers explain who needs these agreements and why they matter.
This is the third in a series of posts on common costly legal mistakes made by founders of early-stage companies.
